Iterum Therapeutics ITRM Stock
1.26 USD
{{ price }}
-3.076920%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqCM
Market Cap
44.96M USD
LOW - HIGH [24H]
1.22
-
1.31 USD
VOLUME [24H]
330.52K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.26 USD
Iterum Therapeutics Price Chart
Iterum Therapeutics ITRM Financial and Trading Overview
| Iterum Therapeutics stock price | 1.26 USD |
| Previous Close | 1.12 USD |
| Open | 1.14 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 900 |
| Day's Range | 1.11 - 1.14 USD |
| 52 Week Range | 0.6 - 7.02 USD |
| Volume | 12.99K USD |
| Avg. Volume | 61.19K USD |
| Market Cap | 14.41M USD |
| Beta (5Y Monthly) | 1.610915 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.26 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1 USD |
ITRM Valuation Measures
| Enterprise Value | -5749957 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.20555556 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.75 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.193 |
Trading Information
Iterum Therapeutics Stock Price History
| Beta (5Y Monthly) | 1.610915 |
| 52-Week Change | -63.90% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7.02 USD |
| 52 Week Low | 0.6 USD |
| 50-Day Moving Average | 1.12 USD |
| 200-Day Moving Average | 1.33 USD |
ITRM Share Statistics
| Avg. Volume (3 month) | 61.19K USD |
| Avg. Daily Volume (10-Days) | 34.67K USD |
| Shares Outstanding | 12.98M |
| Float | 12.83M |
| Short Ratio | 0.92 |
| % Held by Insiders | 1.04% |
| % Held by Institutions | 2.27% |
| Shares Short | 64.29K |
| Short % of Float | 0.50% |
| Short % of Shares Outstanding | 0.50% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -27.72% |
| Return on Equity (ttm) | -150.38% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -29762000 USD |
| Net Income Avi to Common (ttm) | -50823000 USD |
| Diluted EPS (ttm) | -4.24 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 51.82M USD |
| Total Cash Per Share (mrq) | 4 USD |
| Total Debt (mrq) | 31.71M USD |
| Total Debt/Equity (mrq) | 167.26 USD |
| Current Ratio (mrq) | 6.957 |
| Book Value Per Share (mrq) | 1.48 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -24658000 USD |
| Levered Free Cash Flow (ttm) | -132000 USD |
Profile of Iterum Therapeutics
| Country | United States |
| State | N/A |
| City | Dublin |
| Address | Fitzwilliam Court |
| ZIP | D02 YW24 |
| Phone | 353 1 669 4820 |
| Website | https://www.iterumtx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 14 |
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
Q&A For Iterum Therapeutics Stock
What is a current ITRM stock price?
Iterum Therapeutics ITRM stock price today per share is 1.26 USD.
How to purchase Iterum Therapeutics stock?
You can buy ITRM shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Iterum Therapeutics?
The stock symbol or ticker of Iterum Therapeutics is ITRM.
Which industry does the Iterum Therapeutics company belong to?
The Iterum Therapeutics industry is Biotechnology.
How many shares does Iterum Therapeutics have in circulation?
The max supply of Iterum Therapeutics shares is 35.68M.
What is Iterum Therapeutics Price to Earnings Ratio (PE Ratio)?
Iterum Therapeutics PE Ratio is now.
What was Iterum Therapeutics earnings per share over the trailing 12 months (TTM)?
Iterum Therapeutics EPS is -1.26 USD over the trailing 12 months.
Which sector does the Iterum Therapeutics company belong to?
The Iterum Therapeutics sector is Healthcare.
Iterum Therapeutics ITRM included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| NASDAQ HealthCare IXHC | 923.51 USD — |
-0.73
|
— — | 917.75 USD — | 925.61 USD — | — - | — — |
- {{ link.label }} {{link}}